ReShape Lifesciences to Webcast Live at Life Sciences Investor Forum on December 16th
DATE: Thursday, December 16th
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com.
About ReShape Life Sciences
ReShape Lifesciences™ is America's premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band® Program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The ReShape Vest™ System is an investigational (outside the
A real-time solution for investor engagement,
View original content to download multimedia:https://www.prnewswire.com/news-releases/reshape-lifesciences-to-webcast-live-at-life-sciences-investor-forum-on-december-16th-301441199.html
Company Contact: Thomas Stankovich, Chief Financial Officer, 949-276-6042, ir@ReShapeLifesci.com; or Investor Relations Contact: Rx Communications Group, Michael Miller, (917)-633-6086, email@example.com; or Life Sciences Investor Forum: John M. Viglotti, SVP Corporate Services, Investor Access, (212) 220-2221, firstname.lastname@example.org